Skip to main content
OpenTrials
Completed

NCT Number: NCT06346353

Substance Consumption, Personality, and Cognitive Functioning of Chess Players

The aim of this project is to find out if there is a difference in addictive behavior, personality traits, and cognitive abilities between chess players and non-chess players.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit

Mannheim, Germany

About this study

In the present planned study, tournament chess players will be compared with non-tournament chess playing individuals by means of an online survey. Among other things, the investigators want to investigate whether these groups of persons differ in various characteristics such as their consumption behavior (alcohol, tobacco, and drug use), their personality, their depressiveness and mood, or their cognitive abilities. The background is the question whether playing chess could be protective against substance use disorders or could mitigate the manifestation.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all persons from the age of 18 years
  • Inclusion in the group of chess players is based on the existence of a DWZ.
  • Sufficient ability to answer the questionnaires

Exclusion criteria

  • None

Treatment and study plan

Primary outcomes

  1. Substance Craving

    Time frame: baseline

    Mannheimer Craving Scale (MACS), Nakovics, Diehl, Geiselhart, & Mann, 2009

  2. Alcohol Use

    Time frame: baseline

    Alcohol Use Disorders Indentification Scale (AUDIT-C), Bohn, Babor, & Kranzler, 1995

  3. Automatic Alcohol Craving

    Time frame: baseline

    Craving Automated Scale - Alcohol (CAS-A), Vollstädt-Klein, Leménager, Jorde, Kiefer, & Nakovics, 2015

  4. Severity of Nicotine Dependence

    Time frame: baseline

    Fagerstrom Test of Nicotine Dependence (FTND), Heatherton, Kozlowski, Frecker, & Fagerström, 1991

  5. Automatic Cigarette Craving

    Time frame: baseline

    Craving Automated Scale - Cigarette Smoking (CAS-CS), Tan et al., 2022

  6. Smoking Consequences

    Time frame: baseline

    Smoking Consequences Questionnaire (SCQ), Lewis-Esquerre, Rodrigue, & Kahler, 2005

  7. Drug Abuse

    Time frame: baseline

    Drug Abuse Screening Test (DAST-10), Lam et al., 2015

  8. Personality

    Time frame: baseline

    NEO five factor inventory (NEO-FFI), Körner et al., 2008

  9. Depression

    Time frame: baseline

    Beck Depressions Inventar - II (BDI-II) Kühner, Bürger, Keller, & Hautzinger, 2007

  10. Anxiety

    Time frame: baseline

    State Trait Anxiety Inventory (STAI - trait Version), Spielberger, 1983

  11. self-efficacy

    Time frame: baseline

    Self-efficacy expectancy (SWE) Jerusalem & Schwarzer, 1999

  12. coping with stress

    Time frame: baseline

    Brief COPE, Carver, Scheier, & Weintraub, 1989

  13. Inhibition capacity

    Time frame: baseline

    Stop Signal Task (Sebastian et al., 2013)

  14. Working Memory capacity

    Time frame: baseline

    N-back Task (Charlet et al., 2014)

Sponsors and collaborators

Lead sponsor

Central Institute of Mental Health, Mannheim

Other

Registry information

Official study title

Substance Consumption, Personality, and Cognitive Functioning of Chess Players and Non-chess Players - an Online Survey

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Apr 4, 2024
Registry last updated
May 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.